How do you decide between continuous or time limited therapy for CLL?

cll, chronic lymphocytic, treatment, ibrutinib, imbruvica, acalabrutinib, calquence, venetoclax, venclyxto, venclexta, obinutuzumab, zanubrutinib, brukinsa, brutons tyrosine kinase, btk